Lawrenceville, NJ, United States of America

Edmund R Marinelli

This inventor holds 38 USPTO granted patents and 15 published patent applications, plus 6 CIPO patents and 6 EPO patents, primarily in Fluorocarbon Nanoemulsions. Top assignees: Bracco Imaging S.p.a., Bracco International Bv, Bracco Suisse Sa. Active years: 1994-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edmund R Marinelli. Retrieved from https://idiyas.com/inventor/edmund-r-marinelli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 38 (Patent Applications = 15)

% Patents Active = 50.0

CIPO Patents = 6 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 2)

Average Co-Inventor Count = 6.2

ph-index = 12

Forward Citations = 356(Granted Patents)

Location History:

Lawrenceville, NJ (US) (1994 - 2016)
Tucson, AZ (US) (2013 - 2023)

Company Filing History:

11 out of 147

Bracco Imaging S.p.a.

patents

11 out of 108

Bracco International Bv

where one patent can have more than one assignee

Years Active: 1994-2023

Loading Chart...

Areas of Expertise:

Fluorocarbon Nanoemulsions

Diagnostic Peptides

Therapeutic Constructs

Fibrin Binding Peptides

Multivalent Constructs

Aminocarboxylate Ligands

Nonionic Contrast Agents

Gastrin Releasing Peptides

VEGF/KDR Binding Peptides

Endothelial Cell Targeting

Magnetic Resonance Agents

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11826319 - Adjusting particle size in fluorocarbon nanoemulsions (2023-11-28),

2. 11304899 - Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereof (2022-04-19),

3. 10780060 - Adjusting particle size in fluorocarbon nanoemulsions (2020-09-22),

4. 10166200 - Buffered oxygen therapeutics (2019-01-01),

5. 9446155 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy (2016-09-20),

6. 9408926 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy (2016-08-09),

7. 9333272 - Fibrin binding peptide conjugates for diagnostic and therapeutic applications (2016-05-10),

8. 9056138 - Multivalent constructs for therapeutic and diagnostic applications (2015-06-16),

9. 8663603 - Multivalent constructs for therapeutic and diagnostic applications (2014-03-04),

10. 8642010 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy (2014-02-04),

11. 8632753 - Multivalent constructs for therapeutic and diagnostic applications (2014-01-21),

12. 8623822 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy (2014-01-07),

13. 8466107 - Fibrin-binding peptides and conjugates thereof (2013-06-18),

14. 8444954 - Gastrin releasing peptide compounds (2013-05-21),

15. 8420053 - Gastrin releasing peptide compounds (2013-04-16),

Title: The Innovative Journey of Edmund R Marinelli

Introduction: Edmund R Marinelli is a prominent inventor based in Lawrenceville, NJ, known for his substantial contributions to the field of science and technology. With an impressive portfolio of 38 patents, Marinelli has demonstrated remarkable ingenuity, particularly in the development of groundbreaking technologies in nanoemulsions and fluorocarbons.

Latest Patents: Among his most recent inventions is the patent for "Adjusting particle size in fluorocarbon nanoemulsions." This invention focuses on providing innovative devices and methods for adjusting particle size in nanoemulsions of fluorocarbons and perfluorocarbons, utilizing techniques like ultrasonication. Another notable patent is for "Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereof," which details novel formulations of fluorocarbon nanoemulsions that include fluorosurfactants and phospholipids, aimed at enhancing oxygen delivery.

Career Highlights: Throughout his career, Marinelli has made significant strides in the industry, working for noteworthy companies such as Bracco International BV and Bracco Imaging S.p.A. His roles in these organizations have allowed him to influence advancements in imaging and pharmaceutical technologies, contributing greatly to the field's growth.

Collaborations: Marinelli has collaborated with talented professionals, including Palaniappa Nanjappan and Karen E Linder. These partnerships have fostered a creative environment that has led to many of the innovative solutions he is recognized for today.

Conclusion: Edmund R Marinelli's work epitomizes the spirit of innovation, showcasing how one individual can impact technological advancement through persistent research and collaboration. With a rich portfolio of patents, he continues to pave the way for future discoveries in the realms of nanoemulsions and fluorocarbon applications.

Profile summary based on public USPTO records.